Showing 1821-1830 of 2773 results for "".
- Sientra Gives Back: Company Launches Several Breast Cancer Awareness Initiativeshttps://modernaesthetics.com/news/sientra-gives-back-company-launches-several-breast-cancer-awareness-initiatives/2473306/Sientra is launching several initiatives in honor of Breast Cancer Awareness Month. Sientra has partnered with actress and breast cancer survivor, Miranda McKeon; collaborated with the Brem Foundation to launch “Sientra Supports”; and continues to support Re
- L'Oréal USA to Open New Research & Innovation Center in New Jerseyhttps://modernaesthetics.com/news/loreal-usa-to-open-new-research-innovation-center-in-new-jersey/2473305/L'Oréal USA is opening a new, state-of-the-art Research & Innovation (R&I) Center in Clark, New Jersey, replacing its existing facilities that it has occupied in the area for more than six decades. The $140 million development project represents the most significant investment
- Merz Aesthetics Introduces New Lookhttps://modernaesthetics.com/news/merz-aesthetics-introduces-new-look/2473303/Merz Aesthetics has debuted a new corporate visual identity. According to the company, the refreshed look underscores its commitment to putting the definition of beauty back into the hands of the individual through a vibrant and distinct color palette along with strong and joyful photography.
- Allergan Aesthetics and BOTOX Cosmetic Reveal New 'See Yourself' Campaign Casthttps://modernaesthetics.com/news/allergan-aesthetics-and-botox-cosmetic-reveal-new-see-yourself-campaign-cast/2473299/Allergan Aesthetics is unveiling the 25 real patients – of all forms, genders, ethnicities and backgrounds – who were selected to participate in the latest iteration of the BOTOX Cosmetic 'See Yourself' campaign. After receiving nearly 20,000 submissions t
- FDA Issues Safety Alert for SCC and Various Lymphomas in Scar Tissue around Breast Implantshttps://modernaesthetics.com/news/fda-issues-safety-alert-for-scc-and-various-lymphomas-in-scar-tissue-around-breast-implants/2473297/The U.S. Food and Drug Administration (FDA) is informing patients and providers about reports of squamous cell carcinoma (SCC) and various lymphomas located in the capsule or scar tissue around breast implants. “After an initial extensive review, we currently believe that th
- CARE Curriculum Launched by DREAM Initiative from Allergan Aesthetics, SkinBetter Sciencehttps://modernaesthetics.com/news/care-curriculum-launched-by-dream-initiative-from-allergan-aesthetics-skinbetter-science/2473296/The DREAM Initiative®, developed by Allergan Aesthetics and skinbetter science®, has supported the development of a racial equity curriculum for dermatology residency programs. The Curriculum f
- FDA Approves Daxxify from Revancehttps://modernaesthetics.com/news/fda-approves-daxxify-from-revance/2473295/Daxxify™ (DaxibotulinumtoxinA-lanm) from Revance is FDA approved for the temporary improvement of moderate to severe frown lines (glabellar lines) in adults. Daxxify is the first and only neuromodulator stabilized with Peptide Exchange Technology™ (PXT) and is free of both human serum
- Allergan Aesthetics Celebrates 100 Million Syringes of JUVÉDERMhttps://modernaesthetics.com/news/allergan-aesthetics-celebrates-100-million-syringes-of-juvederm/2473294/Drumroll, please…Allergan Aesthetics, an AbbVie company, has produced and shipped 100 million syringes of JUVÉDERM products globally. Since its launch in 2000, the JUVÉDERM Collection of Fillers has grown to where its products are now available in mo
- SkinMedica Launches Firm & Tone Lotion for Bodyhttps://modernaesthetics.com/news/skinmedica-launches-firm-tone-lotion-for-body/2473292/Allergan Aesthetics, an AbbVie company has launched SkinMedica® Firm & Tone Lotion for Body, the line’s first product formulated to prevent and address visible signs of body skin aging for a toned look. SkinMedica says it is clinically proven to diminish the look of crepey
- FDA Grants 510(k)Clearance to LASEROPTEK's HELIOS IV-785 for Aesthetic and Medical Dermatology Usehttps://modernaesthetics.com/news/fda-grants-510kclearance-to-laseropteks-helios-iv-785-for-aesthetic-and-medical-dermatology-use/2473291/The U.S. Food and Drug Administration has granted 510(k) clearance to LASEROPTEK Co., Ltd.’s HELIOS IV-785 laser system for aesthetic and medical dermatology applications. HELIOS IV-785's novel and synergistic combination of 785nm picosecond photoacoustic effect and 1064 &